Dual-target EZH2 inhibitor: latest advances in medicinal chemistry
Future Medicinal Chemistry · 02.08.2024 · 16 (15) · 1561-1582
DOI: 10.1080/17568919.2024.2380243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, online erschienen am 31.07.2024. Verfasst von Lai Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of…. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Enhancer of zeste homolog 2 (EZH2), a histone methyltransferase, plays a crucial role in tumor progression by regulating gene expression. EZH2 inhibitors have emerged as promising anti-tumor agents due to their potential in cancer treatment strategies. However, single-target inhibitors often face limitations such as drug resistance and side effects. Dual-target inhibitors, exemplified by EZH1/2 inhibitor HH-2853(28), offer enhanced efficacy and reduced adverse effects. This review highlights recent advancements in dual inhibitors targeting EZH2 and other proteins like BRD4, PARP1, and EHMT2, emphasizing rational design, structure-activity relationships, and safety profiles, suggesting their potential in clinical applications. [Box: see text].
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology Department of Orthodontics, Sichuan University, Chengdu,…
ORCID-Profile: Shufang Du
Zitieren
APA
Wei, L., Mei, D., Hu, S., & Du, S. (2024). Dual-target EZH2 inhibitor: latest advances in medicinal chemistry. Future Medicinal Chemistry, 16(15), 1561-1582. https://doi.org/10.1080/17568919.2024.2380243
Vancouver
Wei L, Mei D, Hu S, Du S. Dual-target EZH2 inhibitor: latest advances in medicinal chemistry. Future Medicinal Chemistry. 2024;16(15):1561-1582. doi:10.1080/17568919.2024.2380243
BibTeX
@article{Wei2024,
author = {Wei, Lai and Mei, Dan and Hu, Sijia and Du, Shufang},
title = {Dual-target EZH2 inhibitor: latest advances in medicinal chemistry},
journal = {Future Medicinal Chemistry},
year = {2024},
volume = {16},
number = {15},
pages = {1561--1582},
doi = {10.1080/17568919.2024.2380243}
}
EUVIMED